City

Abu Dhabi (1)

Doha (1)

Leiden (1)

Condition

Mendelian Disorders (3)

Congenital Anomalies (1)

De Novo Mutation (1)

Genetic Diseases, Inborn (1)

Genetic Disorder (1)

Hereditary Disorder (1)

Inherited Disease (1)

Novel Mutation (1)

Single-Gene Defects (1)

Overall Status

Enrolling by invitation (1)

Suspended (1)

Unknown status (1)

Sign in for free

Phase

Sponsor

Imperial College London Diabetes Centre (1)

Leiden University Medical Center (1)

Weill Medical College of Cornell University (1)

Collaborator

Hamad Medical Corporation (1)

Weill Cornell Medical College in Qatar (1)

Intervention

sanger and/or next generation sequencing (ngs) (1)

Study Documents

Intervention Type

genetic (1)

Funder Type

Other (3)

Study Type

Observational (3)

mendelian disorders

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Genetics of Mendelian Diseases in Qatar

Suspended

Mendelian Disorders

Doha, Qatar

Hamad Medical Corporation

Jan 30, 2023

Evaluating Prenatal Exome Sequencing Study

Enrolling by invitation

Congenital Anomalies
+2 more

Leiden, Zuid-Holland, Netherlands

Leiden University Medical Centre

Mar 21, 2022

Delineation of Novel Monogenic Disorders in United Arab Emirates

Unknown status

Mendelian Disorders
+6 more

Sanger and/or Next Generation Sequencing (NGS)

Abu Dhabi, United Arab Emirates

Imperial College London Diabetes Centre

Feb 11, 2020